US 11673966
Monoclonal and humanized antibodies to a cancer glycopeptide
granted A61KA61K2039/505A61P
Quick answer
US patent 11673966 (Monoclonal and humanized antibodies to a cancer glycopeptide) held by The Board of Regents of the University of Texas System expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00